Acute Coronary Syndromes

‘An incredible discovery’: Researchers ID a gene that regenerates damaged muscles after a heart attack
How early marijuana use affects the heart later in life
New research points to a better strategy for cardiovascular risk assessment
‘An incredible discovery’: Researchers ID a gene that regenerates damaged muscles after a heart attack
Excess deaths in the US jumped 23% in 2020—COVID-19, heart disease and diabetes all played key roles
MORE »

Imaging & Physiology

AI model predicts a patient’s risk of death—and all it needs is an X-ray
GE Healthcare debuts new AI offering for cardiac imaging
CT perfusion a key tool for evaluating stroke patients—but utilization remains low
Minor impairments in systolic function linked to heart failure, HFrEF in late life
AI model predicts death from cardiovascular disease, coronary artery disease better than other advanced techniques
MORE »

Interventional & Surgery

Uninterrupted OAC therapy for PCI patients leads to cost savings, shorter lengths of stay
Abbott gains CE mark approval for short-term DAPT after stent implantation in high-risk patients
‘A new treatment option’: FDA approves Harmony TPV, says it could delay the need for certain surgeries
Primary PCI boosts 10-year survival rate for STEMI patients 
TMVR for pediatric patients: ‘Acutely effective and safe, with very encouraging results’
MORE »

Heart Rhythm

SGLT2 inhibitors reduce risk of atrial fibrillation, sudden cardiac death in patients with Type 2 diabetes
New and improved: Hospital updates AFib ablation protocols, improves efficiency
FDA grants breakthrough device designation to AI-powered ECG analysis tool
COAPT update: How AFib affects TMVR outcomes
Wearable ECG devices detect AFib among older patients, reducing the risk of stroke
MORE »

Economics & Policy

Endologix acquires medical device company focused on peripheral artery disease
US recommends pause of Johnson & Johnson COVID-19 vaccine due to blood clot risk
Cardiologist takes stand in Derek Chauvin trial, says George Floyd’s death was ‘absolutely preventable’
Uninterrupted OAC therapy for PCI patients leads to cost savings, shorter lengths of stay
New guidelines focus on the management of heart failure patients with secondary mitral regurgitation
MORE »

Heart Failure

New guidelines focus on the management of heart failure patients with secondary mitral regurgitation
How prior hospitalizations affect a heart failure patient’s chances of survival
Beta-blockers raise the risk of heart disease, stroke among people with HIV
Dapagliflozin provides significant benefits for both male and female heart failure patients
How patient-reported data compare to NYHA classifications for evaluating heart failure
MORE »

Prevention & Risk Reduction

New research highlights the close connection between diabetes and cardiovascular issues
How early marijuana use affects the heart later in life
New research points to a better strategy for cardiovascular risk assessment
Metformin shows promise for treating polycystic kidney disease
SGLT2 inhibitors reduce risk of atrial fibrillation, sudden cardiac death in patients with Type 2 diabetes
MORE »

Practice Management

Learn from an expert: How to limit cardiovascular disease among patients with diabetes
New guidelines focus on the management of heart failure patients with secondary mitral regurgitation
SGLT2 inhibitors reduce risk of atrial fibrillation, sudden cardiac death in patients with Type 2 diabetes
Learn from an expert: How to limit cardiovascular disease among patients with diabetes
Treating patients during a pandemic: 3 key ways COVID-19 changed cardiovascular care
MORE »

Structural Heart Disease

Specialists complete first procedure in historic head-to-head TAVR study
Abbott’s next-generation device for tricuspid heart valve repair gains CE mark approval
TAVR comparable to surgery for patients with rheumatic aortic stenosis
What TAVR availability has meant for patients with severe aortic stenosis
TMVR safe and effective for kidney transplant recipients
MORE »

Vascular & Endovascular

Patients with pulmonary arterial hypertension benefit from sotatercept treatment
Johnson & Johnson COVID-19 vaccine being investigated for possible blood clot risk
AstraZeneca COVID-19 vaccine associated with risk of rare, potentially fatal blood clots
Abbott gains CE mark approval for short-term DAPT after stent implantation in high-risk patients
Patients with pulmonary arterial hypertension benefit from sotatercept treatment
MORE »
Design by Adaptivethemes.com